How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

AbelZeta announces updated clinical results for C-CAR031 (AZD7003), a GPC3-targeted armored autologous CAR-T in advanced hepatocellular carcinoma at ESMO Congress 2026

calendar_today November 9, 2026 person Sarah Kelly domain abelzeta-pharma

AbelZeta updated clinical results from the first-in-human study investigating C-CAR031 (now known as AZD7003), a novel glypican-3 (GPC3)-targeted armored CAR-T in advanced hepatocellular carcinoma (HCC), presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain. The post AbelZeta announces updated clinical results for C-CAR031 (AZD7003), a GPC3-targeted armored autologous CAR-T in advanced hepatocellular carcinoma at ESMO Congress 2026 appeared first on AbelZeta .

open_in_new Read original post